Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 3,3 Spiro(2 Tetrahydrofuran)Oxindole. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Rh-catalyzed one-pot route for spiro-oxindoles. High yield, mild conditions. Reliable pharmaceutical intermediate supplier for oncology drug development.
Novel Rh-catalyzed one-pot synthesis for high-purity pharmaceutical intermediates with AURKA inhibitory activity and scalable production capabilities.